The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Decreased C-Reactive Protein Levels in Alzheimer Disease
Open accessAbstract
C-reactive protein (CRP) is an acute-phase reactant that has been found to be associated with Alzheimer disease (AD) in histopathological and longitudinal studies; however, little data exist regarding serum CRP levels in patients with established AD. The current study evaluated CRP levels in 192 patients diagnosed with probable AD (mean age = 75.8 ± 8.2 years; 50% female) as compared to 174 nondemented controls (mean age = 70.6 ± 8.2 years; 63% female). Mean CRP levels were found to be significantly decreased in AD (2.9 µg/mL) versus controls (4.9 µg/mL; P = .003). In adjusted models, elevated CRP significantly predicted poorer (elevated) Clinical Dementia Rating Scale sum of boxes (CDR SB) scores in patients with AD. In controls, CRP was negatively associated with Mini-Mental State Examination (MMSE) scores and positively associated with CDR SB scores. These findings, together with previously published results, are consistent with the hypothesis that midlife elevations in CRP are associated with increased risk of AD development though elevated CRP levels are not useful for prediction in the immediate prodrome years before AD becomes clinically manifest. However, for a subgroup of patients with AD, elevated CRP continues to predict increased dementia severity suggestive of a possible proinflammatory endophenotype in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mean CRP levels decreased significantly in AD in study conducted by O'Bryant et al. (2009) [48].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [48]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Research works printed but not linked: 5
- Ridker PM, 1998, J Investig Med, 46, 391
- Kuller LH, 1996, Multiple Risk Factor Intervention Trial. Am J Epidemiol, 144, 537
- Waring S., 2008, Texas Public Health J, 60, 9
- O’Bryant SE, 2009, Journal of Alzheimer’s Disease, 17, 1051
- Diaz-Arrastia R., International Conference on Alzheimer’s Disease
Cited by
Sorted by citations
Items 101–103 of 103
Noppert, G. A., Stebbins, R. C., Zhang, K. P., Kobayashi, L. C., Langa, K. M., Levin, B., Li, C., & Aiello, A. E. (2026) · BMC Biology · doi:10.1186/s12915-026-02679-4
Zhang, J., Zhu, Y., Zhang, Q., Dai, Y., Liu, H., Shi, J., Yanghua, J., & Chen, Q. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113527
A novel rat model of ovarian cancer and cisplatin chemotherapy-related cognitive impairment
Lomeli, N., Pearre, D. C., Lepe, J. J., Argueta, D. A., Arellano, M. A., Gupta, K., Taylor, T. H., & Bota, D. A. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101373
Metadata
- Authors
- O'Bryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., Bottiglieri, T., Massman, P., & Diaz-Arrastia, R.
- Affiliations
- Department of Neurology, F. Marie Hall Institute for Rural & Community Health, Texas Tech University Health Sciences Center, Lubbock, Texas,
- Marshfield Clinic Research Foundation (US)
- Texas Tech University (US)
- University of North Texas Health Science Center (US)
- The University of Texas Southwestern Medical Center (US)
- Baylor University Medical Center (US)
- Baylor College of Medicine (US)
- Venue
- Journal of Geriatric Psychiatry and Neurology
- Publisher
- SAGE Publications
- Published
- 2009-11-20
- Volume
- 23
- Issue
- 1
- Pages
- 49-53
- ISSN
- 0891-9887 (ISSN-L)
- 1552-5708
- PMC
- PMC3204581
- OpenAlex
- W2056433678
- Cited by
- 103
- References
- 42
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 6 · 2023: 10 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 1 · 2018: 9 · 2017: 6 · 2016: 1 · 2015: 8 · 2014: 5 · 2013: 13 · 2012: 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Geriatric Psychiatry and Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01 AG17869, P30AG012300, P30AG-12300)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- C-reactive protein, Alzheimer's disease, acute phase proteins, dementia severity, Clinical Dementia Rating, Mini-Mental State Examination, inflammation, prodromal Alzheimer's disease, endophenotypes, serum biomarkers
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, C-Reactive Protein, Dementia, Female, Humans, Immunoassay, Male, Mental Status Schedule, Middle Aged, Predictive Value of Tests, Psychiatric Status Rating Scales, Severity of Illness Index, Time Factors, Biomarkers, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
